BioMed Research International

BioMed Research International / 2016 / Article
Special Issue

Laboratory Medicine 2016

View this Special Issue

Research Article | Open Access

Volume 2016 |Article ID 7508763 | 4 pages |

Mean Platelet Volume in Mycobacterium tuberculosis Infection

Academic Editor: Giulio Mengozzi
Received21 Mar 2016
Revised30 May 2016
Accepted01 Jun 2016
Published22 Jun 2016


Introduction. Mean platelet volume (MPV) has been thought as a useful index of platelet activation. It is supposed that MPV is also associated with several inflammatory and infectious diseases. Korea still has a high incidence of tuberculosis (TB). The aim of this study was to investigate MPV as an inflammatory marker in TB patients. Materials and Methods. MPV were determined in 221 patients with TB and 143 individuals for control group. MPV was estimated by an Advia 2120 (Siemens Healthcare Diagnostics, Tarrytown, NY, USA). Results. In the TB patient group, a positive correlation was found between CRP and MPV. Age and MPV had a positive correlation in TB patient group. Conclusions. We conclude that there is a significant relation between MPV and inflammatory conditions. MPV can be an inflammatory marker to determine the disease activity in TB patients.

1. Introduction

Platelet is well known to be involved in the hemostasis. However nowadays, its different roles are attracting interest, such as actions on inflammation and immunity. Platelets have been widely studied in inflammation-induced atherosclerosis, as well as in thrombosis [1]. Due to the development of the automated complete blood count (CBC) analyzer, platelet indices have been one of the fastest and easiest tests to verify platelet function. Among various platelet indices, the mean platelet volume (MPV) reflects the size of platelets and has been suggested as a useful index of platelet activation [2].

MPV has been also investigated in several infectious diseases such as hepatitis B or mycobacterial infection [3, 4]. Tuberculosis (TB) is one of the most problematic and important diseases threatening public health in Korea. Korea still has a higher prevalence of mycobacterial infection than most other developed countries [5]. Annually, 90 individuals per 100,000 people are newly diagnosed with TB in Korea [6]. Early diagnosis, proper treatment regimen, and determining the activity of TB are important for the regulation of TB. There is no reliable parameter to determining the activity of TB except follow-up of the culture growth of mycobacteria bacilli. A few studies have investigated the relations between TB and MPV [7, 8]. The results were controversial. In this study, we evaluated the MPV in TB patients who were confirmed positive by culture and investigate the meaning of MPV in determining the activity of TB by comparing with C-reactive protein (CRP) as an inflammatory marker.

2. Materials and Methods

This study included 221 patients who had positive results on conventional culture tests for mycobacterial species seen at our hospital between January 2011 and April 2012. As the control group, we selected 143 individuals who visited the same hospital for medical check-ups. Extensive chart reviews were done to exclude any individuals with hypertension, diabetes, or smoking from the control group. To ensure that patients had Mycobacterium tuberculosis (MTB) infections, the patient group comprised nonoverlapping individuals so that positive results could be identified in a conventional culture study. For solid cultures, 3% Ogawa medium was used. Inoculated medium was incubated for at least 8 weeks at 37°C, in a MGIT 960 incubator (Becton, Dickinson and Company, MD, USA). Culture results were checked weekly. Blood was sampled by venipuncture at antecubital fossa and collected in tubes containing ethylenediaminetetraacetic acid (EDTA). MPV was measured in an Advia 2120 (Siemens Healthcare Diagnostics, Tarrytown, NY, USA) within 2 hours from sampling.

Data were tested for normal distribution using the Kolmogorov-Smirnov test. Statistical comparison was calculated by an unpaired -test. Spearman’s coefficient of rank correlation and partial correlation coefficient were used to evaluate the association between MPV, platelet count, CRP, and age. Regression analysis was performed to make regression equation and calculate coefficient of determination. values < 0.05 were considered to indicate statistical significance. The statistical analyses were performed using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) and Excel 2007 (Microsoft, Redmond, WA).

3. Results

The patients’ characteristics are summarized in Table 1. The mean age of the TB subjects was 55.86 years, while the mean age of controls was 44.00 years, respectively. Male and female ratio is 1.66 in TB patient group and 1.01 in control group, respectively.

Total number of patients221143
Mean age (range)55.86 (11–96) years44.00 (13–71) years
Correlation between MPV and agerho = −0.067, rho = 0.235,
Male : female138 : 8372 : 71
Types of specimens culturedN/A
 Bronchial fluid9
 Pleural fluid8
 Urine 4
 Pericardial fluid2

Cerebrospinal fluid, joint fluid, pus, and so forth.
By Spearman’s coefficient of rank correlation.
N/A, not applicable.

The mean MPV did not differ significantly between the patients (8.03 fL) and controls (7.96 fL). However the platelet count was significantly higher in the TB patients (303 × 109/L) than in the controls (258 × 109/L).

Among control group, no correlation was found between MPV and the individuals’ age, while among TB patient group, positive correlation was found between MPV and patient age (correlation coefficient; , ) (Figure 1) and between MPV and CRP (correlation coefficient; , ) (Figure 2) by Spearman’s coefficient of rank correlation. The partial correlation coefficients of MPV with CRP after adjusting for age are presented in Table 2. However there was no correlation between CRP and platelet count.

VariablesMPV (fL)

CRP (mg/L)0.2070.007
Platelet count (×109/L)−0.0180.819

, correlation coefficient.

4. Discussion

Although platelet indices such as MPV have been routinely tested in clinical laboratory using automated hematologic analyzer, their role in the diagnosis and management of diseases has not been fully investigated yet [4, 9]. In platelet study, many investigations have focused on the change of platelet count such as thrombocytosis in inflammatory conditions or its role in hemostasis [10]. Although the function of platelets in hemostasis has been studied thoroughly, more recent evidence has been accumulated in an important role for platelets in the host inflammatory and immune responses [11]. As well as participating in blood coagulation, platelets can act as one of the inflammatory or immune effector cells by releasing inflammatory mediators, activating complement factors, interacting with foreign organisms such as parasites, viruses, and bacteria, and enhancing vascular permeability [1, 2, 10, 11]. Recently, many studies have suggested the importance of MPV as an inflammation marker in some chronic inflammatory disorders, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and psoriasis [2]. However, the results have been controversial and only a few studies have investigated the role of MPV in infection and even fewer have studied the role of MPV specifically in TB infection. To the best of our knowledge, the present study is the largest study investigating MPV as an inflammatory marker in TB patients.

We have found direct relation between MPV and CRP in the TB patient group. As CRP is used commonly as an acute-phase reactant and an inflammatory marker, the result showed that MPV could be used as an inflammatory marker in disease activity assessment in TB. Platelets play a pathophysiological role in making multiple microthromboses around tuberculous cavities to prevent dissemination of the infection [12]. Increasing MPV can be explained by the fact that younger platelets being larger than mature ones are released from bone marrow to the peripheral blood circulation, as platelets are consumed [13]. Recently, it has been reported that various inflammatory conditions increase platelet size and activity [1, 2, 8, 14]. Contrary to our study, Zareifar et al. reported a negative relationship between MPV and serum CRP level. Contradictory results may be related to the characteristics of the studied groups of patients. In the study of Zareifar et al., the subjects were 100 children with all kinds of infectious and inflammatory diseases not defined as acute or chronic. In active phase or attacks of the chronic autoimmune inflammatory disorders, small platelets can circulate dominantly due to the excessively enhanced production of proinflammatory cytokines and acute-phase reactants which decreases the size of platelets [15]. It can also explain the phenomenon that MPV becomes higher after the anti-inflammatory treatment in RA. Gasparyan et al. explained this phenomenon by hypothesizing that high-grade inflammatory diseases, such as active rheumatoid arthritis or attacks of familial Mediterranean fever, result in low levels of MPV because of intensive consumption of large platelet, while low-grade inflammatory diseases or states, such as smoking, diabetes, psoriasis, Behcet’s disease, or ankylosing spondylitis, have the opposite effect on MPV because the spleen contains approximately one-third of all the body’s platelets which are relatively larger and hemostatically more active than platelets in the systemic circulation [16, 17]. Several studies investigating the relation between MPV and TB have controversial results. Tozkoparan et al. found that the MPV was higher in patients with active TB than in non-TB subjects [14], while Baynes et al. found MPV to be low in patients with active TB [18]. Şahin et al. reported that there was no statistical difference in MPV values between TB patients group and non-TB subjects [8]. However in all those studies, they just compared MPV values of TB patients and non-TB subjects and did not investigate the relation between MPV and CRP.

The effect of age on MPV remains controversial [10]. In this study, in contrast with control group, the increasing tendency of MPV with age was identified in the patient group. We excluded individuals with pathological conditions that may affect MPV values, such as hypertension and smoking from the subjects by means of an extensive chart review. The control group showed no association between MPV and age. This suggests that the platelets of older patients respond more readily to inflammatory or infectious conditions. Aging is known to be associated with increased levels of cytokines and proinflammatory markers. It can result from age-related changes in the immune system and increased secretion of cytokines by adipose tissue [19].

This study had several limitations. Our only inclusion criterion for the patient group was a positive MTB culture; other clinical data, such as medication and duration of disease, were not analyzed. In a future study, these clinical factors should be investigated to rule out their effect on platelet indices.

5. Conclusions

In our study we suggest that the changes in MPV are according to CRP and age in TB patients. We found a significant relation between MPV and inflammatory conditions. MPV can be an inflammatory marker measured by the easiest and fastest way to determine the disease activity in TB patients.


English editing was supported by in primary draft.

Competing Interests

The authors have no conflict of interests to report.

Authors’ Contributions

Sun Young Cho and Tae Sung Park contributed equally to this work and both are considered senior authors. All of the authors contributed to this study as follows. Min Young Lee was involved in data collection, paper writing, and statistical analysis. Young Jin Kim and Hee Joo Lee provided opinions for interpreting results of infection markers in TB patients. Sun Young Cho and Tae Sung Park took part in the whole progress of this study such as data analysis, drawing conclusion, and writing and revising paper.


This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A1A3A04004875).


  1. A. Y. Gasparyan, “Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets,” Current Pharmaceutical Design, vol. 18, no. 11, pp. 1447–1449, 2012. View at: Publisher Site | Google Scholar
  2. A. Y. Gasparyan, L. Ayvazyan, D. P. Mikhailidis, and G. D. Kitas, “Mean platelet volume: a link between thrombosis and inflammation?” Current Pharmaceutical Design, vol. 17, no. 1, pp. 47–58, 2011. View at: Publisher Site | Google Scholar
  3. S. Y. Cho, J. J. Yang, E. You et al., “Mean platelet volume/platelet count ratio in hepatocellular carcinoma,” Platelets, vol. 24, no. 5, pp. 375–377, 2013. View at: Publisher Site | Google Scholar
  4. W.-Y. Shin, D.-H. Jung, J.-Y. Shim, and H.-R. Lee, “The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population,” Platelets, vol. 22, no. 6, pp. 442–446, 2011. View at: Publisher Site | Google Scholar
  5. World Health Organization, Global Tuberculosis Report 2015, WHO/HTM/TB/2015.22, World Health Organization, Geneva, Switzerland, 2015,
  6. S. Y. Cho, M. J. Kim, J.-T. Suh, and H. J. Lee, “Comparison of diagnostic performance of three real-time PCR kits for detecting Mycobacterium species,” Yonsei Medical Journal, vol. 52, no. 2, pp. 301–306, 2011. View at: Publisher Site | Google Scholar
  7. G. Gunluoglu, E. E. Yazar, N. S. Veske, E. C. Seyhan, and S. Altin, “Mean platelet volume as an inflammation marker in active pulmonary tuberculosis,” Multidisciplinary Respiratory Medicine, vol. 9, no. 1, article 11, 2014. View at: Publisher Site | Google Scholar
  8. F. Şahin, E. Yazar, and P. Yıldız, “Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis,” Multidisciplinary Respiratory Medicine, vol. 7, article 38, 2012. View at: Publisher Site | Google Scholar
  9. S. Y. Cho, J. J. Yang, Y.-S. Nam, J.-T. Suh, T. S. Park, and H. J. Lee, “Mean platelet volume in patients with increased procalcitonin level,” Platelets, vol. 24, no. 3, pp. 246–247, 2013. View at: Publisher Site | Google Scholar
  10. H. Demirin, H. Ozhan, T. Ucgun et al., “Normal range of mean platelet volume in healthy subjects: Insight from a large epidemiologic study,” Thrombosis Research, vol. 128, no. 4, pp. 358–360, 2011. View at: Publisher Site | Google Scholar
  11. C. N. Jenne, R. Urrutia, and P. Kubes, “Platelets: bridging hemostasis, inflammation, and immunity,” International Journal of Laboratory Hematology, vol. 35, no. 3, pp. 254–261, 2013. View at: Publisher Site | Google Scholar
  12. C. Kuhn and F. Askin, “Lung and mediastinum,” Anderson's Pathology, vol. 1, pp. 833–954, 1985. View at: Google Scholar
  13. B. V. Kural, A. Örem, G. Çimşit, H. A. Uydu, Y. E. Yandi, and A. Alver, “Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients,” Clinica Chimica Acta, vol. 332, no. 1-2, pp. 23–30, 2003. View at: Publisher Site | Google Scholar
  14. E. Tozkoparan, O. Deniz, E. Ucar, H. Bilgic, and K. Ekiz, “Changes in platelet count and indices in pulmonary tuberculosis,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 8, pp. 1009–1013, 2007. View at: Publisher Site | Google Scholar
  15. S. Zareifar, M. R. Farahmand Far, F. Golfeshan, and N. Cohan, “Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP,” Journal of Clinical Laboratory Analysis, vol. 28, no. 3, pp. 245–248, 2014. View at: Publisher Site | Google Scholar
  16. A. Y. Gasparyan, A. Sandoo, A. Stavropoulos-Kalinoglou, and G. D. Kitas, “Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy,” Rheumatology International, vol. 30, no. 8, pp. 1125–1129, 2010. View at: Publisher Site | Google Scholar
  17. D. Bakovic, N. Pivac, D. Eterovic et al., “Changes in platelet size and spleen volume in response to selective and non-selective β-adrenoceptor blockade in hypertensive patients,” Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 4, pp. 441–446, 2009. View at: Publisher Site | Google Scholar
  18. R. D. Baynes, T. H. Bothwell, H. Flax et al., “Reactive thrombocytosis in pulmonary tuberculosis,” Journal of Clinical Pathology, vol. 40, no. 6, pp. 676–679, 1987. View at: Publisher Site | Google Scholar
  19. Y. Feng, H. Yin, G. Mai et al., “Elevated serum levels of CCL17 correlate with increased peripheral blood platelet count in patients with active tuberculosis in China,” Clinical and Vaccine Immunology, vol. 18, no. 4, pp. 629–632, 2011. View at: Publisher Site | Google Scholar

Copyright © 2016 Min Young Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2216 Views | 448 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.